|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
FY2019
12 months to Jun 30, 2019
|
FY2018
12 months to Jun 30, 2018
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Amortization of intangibles | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expenses | |||||
| Loss on sale of intangible asset | |||||
| Asset impairment charges | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income (expense), net: | |||||
| Loss on extinguishment of debt | |||||
| Investment income | |||||
| Interest expense | |||||
| Other | |||||
| Total other expense, net | |||||
| Loss before income tax | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Loss per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...